Compare Vanguard's VBR and other small/mid-cap value ETFs by performance, cost, and factors. See here for top picks and ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the "Company"), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive ...

Major stock indexes closed higher Wednesday ahead of AI darling Nvidia's highly anticipated quarterly results after the bell, ...

The K-shaped economy has been a growing problem for decades, made worse by the loss of guaranteed worker pensions, the rise of the gig economy, increasing health-care inflation, the high cost of ...

When someone tells you that AI is going to replace human intelligence, you can honestly tell them that, as of this writing, ...

US stocks were hammered on Thursday as an abrupt midday reversal in markets followed a blockbuster earnings report from ...

The authors have performed a potentially valuable new kind of analysis in connectomics, mapping to an interesting developmental problem of synaptic input to sensory neurons. While the analysis itself ...

The Labor Department is finally releasing the jobs report for September, which was delayed for weeks due to the government shutdown. It is expected to show the economy added around 50,000 jobs that ...

Background Expanding treatment for hypertension requires ensuring access to affordable, high-quality blood pressure (BP) lowering medications. We describe the design, implementation and evaluation of ...

Wall Street’s main stock indices fell on Thursday after an initial wave of optimism surrounding Nvidia’s latest results. The ...

This latest corporate clash has Alkermes working to beat back a challenge from H. Lundbeck for sleep disorder drug developer Avadel Pharmaceuticals.